Tag-Ulan COPD Checklist: Are Your Patients Protected This Season?

Practical strategies to help reduce exacerbation risk and support consistent symptom control during the rainy months.

Respiratory | COPD | NovartisPro

 

During the rainy season, COPD patients may face increased symptom instability linked to environmental triggers and respiratory infections.1 A structured maintenance approach can help sustain symptom control and reduce exacerbation risk. Here is a quick practice checklist: 2

 

ultibro_breezhaler

1) Ensure daily maintenance therapy adherence

Once-daily options may support routine consistency

copd_breathe

2) Reinforce correct inhaler technique

Improper inhalation reduces delivered dose effectiveness

copd_symptom

3) Assess symptom variability

Watch for worsening dyspnea or increased rescue medication use

copd_dosing

4) Remind patients of proper use timing

Same time daily dosing supports consistent control

Image
copd_bronchospasm

5) Clarify limitations of therapy

Maintenance bronchodilators are not for acute bronchospasm

 

Blue letters on a white background Description automatically generated

5/F Ayala North Exchange Building Tower 1, Ayala Avenue corner Amorsolo Sts., Brgy. San Lorenzo, Makati City, Metro Manila Tel. No.: +63 2 7368 7777

 

 

References:

1. Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Maccallum P, Meade TW, Jeffries DJ, Johnston SL, Wedzicha JA. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001 Nov 1;164(9):1618-23. doi: 10.1164/ajrccm.164.9.2105011. PMID: 11719299.

2. Indacaterol/Glycopyrronium (Ultibro) Prescribing Information

This material is supported by Novartis. The content is intended for Healthcare Professionals for medical educational purposes only. Novartis does not engage in the promotion of unregistered products or unapproved indications. Please consult local Prescribing Information for registration/product license details. For suspected adverse drug reaction, kindly report through [email protected] or call +63 2 7368 7777.

For Healthcare Professionals Only | Full Prescribing Information Available Upon Request | FA-11705199-JUN2026– JUN2028

Tags

  • Respiratory
  • COPD